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Few naturalintergenotypic hepatitis C virus (HCV) recombinants havebeen characterised, and onlyRF1 2k/1b has demonstrated
widespread transmission. The near-full length genome sequences for two cases of 2k/1b recombinants (CYHCV037 and
CYHCV093) sampled in Cyprus were obtained using strain-speciﬁc RT-PCR ampliﬁcation and sequencing protocols. Sequence
analysis conﬁrmed their similarity with the original RF1 2k/1b strain from St. Petersburg, N687. These two isolates signiﬁcantly
contribute to the sequence data available on this recombinant and conﬁrm its increasing spread among individuals from Eastern
Europe, anditsassociationwithtransmissionthroughintravenousdrug use.Phylogenetic analysesrevealclusteringofthesequence
3 to the recombination point, not seen in the topology of the 5 sequences, implying a more complicated evolutionary history
than that held to date. The increasing cases of HCV recombinant strains underline the requirement of their contribution to the
standardised rules of HCV classiﬁcationand nomenclature, molecular epidemiology, diagnosis, and treatment.
1.Introduction
The hepatitis C virus (HCV) is a single-stranded positive-
sense RNA virus, belonging to the Flaviviridae family, and
exhibits substantial global sequence diversity [1, 2]. The
heterogeneityoftheHCVgenomehas ledtoa proposed con-
sensus of six genotypes (1–6) and numerous closely related
s u b t y p e s( a ,b ,c , ...)[ 3]. Until 2001, HCV was thought to
evolve in a clonal manner, with diversity generated through
the accumulation of mutations. However, several events of
inter- and intragenotypic homologous recombination have
been reported to date from various parts of the world [4–
12]. Most of these strains appear to be isolated events and
do not appear to be circulating in infected populations. A
2k/1b recombinant was found in St. Petersburg, Russia [7],
thought to have emerged by homologous recombination
during minus-strand synthesis via template switching [13],
and seems to be circulating among intravenous drug users in
Russia. Isolates of this strain, labelled RF1 2k/1b, have also
been found in Ireland, Estonia, Uzbekistan, Western Siberia,
and France [14–18].
In a recent study of HCV strains circulating in Cyprus,
two putative recombinant isolates were discovered among
the HCV-infected population [19], where discordance was
observed between the classiﬁcation of two distinct regions
of the genome. Consequently, in this study, the near-full
genomes of these strains have been sequenced using strain-
speciﬁc protocols, and they have been conﬁrmed as variants
of RF1 2k/1b, conﬁrming a widespread transmission of this
strain, and providing more sequence data that reveal a
complex evolutionary history.
2.Results
2.1. RT-PCR and Sequencing. The strain-speciﬁc near-
full genome ampliﬁcation and sequencing protocols were
designed and successfully applied to the two strains under
investigation. Due to genetic variations between the two iso-
lates, not all PCR and sequencing primers were appropriate
for both, resulting in two slightly designs (see Figure 1 for
CYHCV037 and Figure 2 for CYHCV093 in Supplementary
Material available online at doi: 10.1155/2011/710438).2 Advances in Virology
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Figure1:Simplotanalysesofthetwo2k/1brecombinantcandidatestrains,showingpercentage sequencesimilarityovernucleotideposition.
(a, c) are for strain CYHCV037, and (b, d) for strain CYHCV093. The plots on the top are the results of a genotype-level analysis, with
genotypes corresponding to line colours annotated below the plots. The bottom plots are the results of a subtype-level analysis, once the
genetically closest parental genotypes had been determined using the top plots. The subtypes corresponding to the coloured lines are
annotated below the plots.
Allresultingsequencereadingswereclear,implyingnomixed
infections in the samples in question.
2.2. Characterisation of Recombinant Strains. During a study
of the molecular epidemiology of HCV infection in the
general population of Cyprus, two samples were found to be
s u b typ e2 ki nt h eC o r e - E 1r e gi o n ,a n d1 bi nt h eN S 5 Br e gi o n
[19]. The samples were taken from two Georgian males (lab
codes CYHCV037 and CYHCV093), aged 32 and 39 years at
t h et i m eo fs a m p l i n g .T h es t a t e dr o u t e so ft r a n s m i s s i o nw e r e
unsafe sexual practises and intravenous drug use.
The near-full length sequences (nt. 87-9287, positions
according to H77, GenBank accession no. NC 004102)
were successfully derived from the two samples from 5-6
overlapping PCR fragments. To characterise the sequences,
compare them to classiﬁed reference strains, and investigate
the event of recombination along the length of the sequence,
SimPlot, Bootscan, and phylogenetic analyses were carried
out. A Simplot graph was constructed at ﬁrst on a genotype
level using consensus sequences derived from references,
and, following determination of the parental genotypes,
on a subtype level of the parental genotypes (Figure 1).Advances in Virology 3
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Figure 2: Bootscan plot of percentage permuted trees over nucleotide position across the full length of the 2k/1b recombinant strains. (a, b)
are for the strains described inthis study and (c,d) for the onlynear-full 2k/1b genomessubmitted to GenBank to date. Strainidentiﬁers are
indicated at the top left corner of each plot. In brackets are the GenBank accession numbers of the sequences. The annotation below shows
the HCV subtype of the consensus sequences corresponding to each line colour in the plots.
This clearly demonstrates that the strains described here
are more similar to genotype 2, speciﬁcally 2k, on the 5
side of their genomes, and more similar to genotype 1,
speciﬁcally 1b, on the 3 side of their genomes, with a point
of recombination in the NS2 region, after position 3,000
(position according to strain H77). Bootscan plots were
constructed for each sequence using reference sequences
of the parental genotypes 1b and 2k as well as the only
two available reference sequences for 2k/1b, N687 (GenBank
accession number AY587845) and M21 (GenBank accession
number FJ821465) (Figure 2). The results conﬁrm that
strains CYHCV037 and CYHCV093 are 2k/1b recombinant
strains, with a recombination point in the same genomic
location as the reference 2k/1b isolates. The nucleotide and
deduced amino acid sequences of the two strains found
in Cyprus were according to the original Russian N687
strain, with no insertions or deletions. Analysis by visual
inspection of nucleotide and amino acid alignments in
the NS2 region spanning the stated crossover point revealed
a high degree of similarity between all recombinant strains
reported in this study and the ones previously reported (data
not shown). The two strains here are identical to the Russian
N687 isolate in their partial 5 noncoding region. Also, in
the interferon-sensitivity-determining region (ISDR) of the
NS5A sequence, the amino-acid sequences of the two strains
in this study are identical to those of the N687 isolate, and
therefore identical to the “wild-type” subtype 1b associated
with interferon resistance [13, 20].
Subsequently, phylogenetic trees were constructed for
the regions on either side of the recombination point
(Figure 3). Additional closely related sequences derived from
HCVBLAST searches were used in the analyses and these are
Acc. No. AY070214 and AY070215, both 2k/1b strains, used
i nt h et r e eo ft h e5  regionofthe genome,and EU155337and
EU155333, both 1b, used in the tree of the 3 segment. The
partial regions ofthetwostrains describedhere groupwithin4 Advances in Virology
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Figure 3: Neighbour-Joining trees for (a) the region 5 of the recombinationpoint and (b) the region 3 of the recombinationpoint, as seen
by the indications on the genome maps above each tree, for the 2k/1b recombinant strains identiﬁed in this study (highlighted in black),
other 2k/1b sequences obtained from GenBank, and reference stains of the corresponding parental genotypes. The trees are rooted with
1b and 2k strains, respectively. Grouping can be seen within the corresponding parental subtypes and is highlighted with coloured boxes.
Numbers at branch nodes indicate the percentage bootstrap support for 1,000 replicates. The scale at the bottom left of each tree indicates
the divergence between any two sequences obtained by summing the branch lengths between them.Advances in Virology 5
the 2k and 1b subtypes, respectively, with a bootstrap value
of 100. All 2k/1brecombinants clustertogetherin both trees,
within the subtype group, with bootstrap support >98. The
1b tree (Figure 3(b)) presents grouping of CYHCV093 with
strainN687andCYHCV037withstrainM21,withbootstrap
support of 63 and 100, respectively, whereas the topology of
the 2k/1b cluster within the 2k subtype (Figure 3(a))d o e s
not present any statistically signiﬁcant subgroups (bootstrap
support values <55).
2.3. Nucleotide Sequence Accession Numbers. GenBank acces-
sion numbers for the near-full genome nucleotide sequences
obtained in this study are HQ537005 for strain CYHCV037
and HQ537006 for strain CYHCV093.
3.Discussion
The natural 2k/1b recombinant, RF1 2k/1b, was ﬁrst identi-
ﬁed in 2002 in St.Petersburg, Russia in ﬁve intravenous drug
users [7], one of which was later sequenced along the full
open reading frame (isolate N687, acc. no. AY587845) [13].
Since then, several other RF1 infections have been identiﬁed
in individuals from countries of Eastern Europe and former
members of the Soviet Union [14–16, 18]. The most recently
found isolate (M21, Acc. no. FJ821465) [17] and the original
N687strain are theonlyonesthathavebeensequencedalong
the complete genome to date.
In the investigation of partial sequences from samples of
the HCV-infected population of Cyprus there was evidence
for two putative 2k/1b recombinant isolates. These samples
were characterised in more detail by near-full genome
sequencing and analysis, by designing strain-speciﬁc RT
nested PCR and sequencingprotocols. All resulting sequence
readings were clear, implying that the strains in question are
recombinants and not mixed infections of pure subtypes 2k
and1b.TheresultsofSimplotandBootscananalysesconﬁrm
that isolates CYHCV037 and CYHCV093 are genetically
close variants of the RF1 2k/1b recombinant strain, with the
crossoverpointinthesame genomiclocationasthereference
N687 and M21 strains.
The epidemiological characteristics of the patients from
whom the strains were derived were similar to the charac-
teristics of the individuals carrying the RF1 2k/1b strains
discovered to date. These demonstrate and conﬁrm a trend
pointing towards young men from countries of the former
Soviet Union and Eastern Europe, and injecting drug use as
the main risk behaviour. Hence, RF1 2k/1b appears to be
circulating in small populations more than any other HCV
recombinant, as several cases of infections have now been
reported.Thediscoveryofthesestrains inCyprusemphasises
the increasing transmission of this type in various European
regions.
AsonlytwoRF1 2k/1bgenomesequenceshavebeensub-
mitted to GenBank to date [13, 17], the sequences described
here doublethe publiclyavailablenear-full genomesequence
information for this strain. It has therefore been diﬃcult to
make conclusions regarding the molecular evolution of this
strain, but with the addition of two more near-full genomes,
hypotheses about this can now begin to be formulated. In
the phylogenetic analyses carried out here, the recombinants
group closely together forming distinct subclusters within
the parental subtype group, demonstrating a low divergence
between them and an evolutionary separation from the
pure subtypes, in agreement with previous ﬁndings [15].
However, the RF1 also demonstrated statistically signiﬁcant
biphyletic separation of its isolates. This was observed for
the 1b sequences on the 3 side of the recombination point,
but not for the 2k sequences on the 5 side of the genome.
It is important to note that not all 2k/1b strains found
have been sequenced fully and the sequence data available
for the analyses of the diﬀerent regions was not the same
and was limited. Only in the analysis for the sequences 5
of the recombination site were there more strains available
than those that have been sequenced along the full genome.
Therefore, from the data available, the observed diﬀerence
in clustering behaviour between the regions on either side
of the recombination point could signify that the original
recombination event took place between closely related 2k
quasispecies and genetically diverse 1b species in the host,
present perhaps due to multiple points of infection through
unsafe injecting drug use, or due to 1b quasispecies diversity,
providing a number of recombination events, and the spread
from two of these is represented in the strains that have
been sequenced to date. Hence, the two strains discovered
in Cyprus not only provide more sequence information for
the 2k/1b recombinant strain but also provide a diﬀerent
view on the evolutionary history of this strain than that
which has been held to date. With theaddition ofmore near-
full genomes within this recombinant type, a more accurate
evolutionary picture of this strain will become apparent.
The serendipitous identiﬁcation of two variants of the
HCV RF1 2k/1b in Cyprus was the result of a molecular
investigation across the near-full genome. The results of
this study highlight the opinion that the actual prevalence
of this HCV type has been underestimated and that its
molecular evolution is possibly more complicated than the
hypothesis of one recombination point giving rise to one
single common evolutionary ancestor. Epidemiologically,
HCV recombinant RF1 2k/1b appears to be spreading in
Europe and the Mediterranean region, through population
movements of intravenous drug users. This recombinant
is the most widespread and broadly distributed for HCV,
highlighting the need to better investigate recombination in
epidemiological studies, to include it in the considerations
for the criteria of HCV classiﬁcation and nomenclature, and
to give greater consideration to their diagnosis and clinical
management.
4.Methods
4.1. Samples. During the study of the molecular epidemiol-
ogy of HCV infection in the general population of Cyprus,
discrepancies were found in the subtype classiﬁcation of
two genomic regions for two samples, which were found
to be subtype 2k in the Core-E1 region, and 1b in the
NS5B region [19]. These strains were considered putative
2k/1b recombinants and were therefore selected for near-
full genome sequencing. The samples were taken from two6 Advances in Virology
consenting Georgian male patients. Patient CYHCV037, 32
years old when sampled in 2005, had been ﬁrst diagnosed
HCV-seropositive in 2003 and stated sexual transmission
as the possible route of infection. Patient CYHCV093, 39
years old when sampled in 2007, had been diagnosed HCV-
seropositive in 2000 and stated intravenous drug use as the
transmission route. Neither individual had taken antiviral
therapy at the time of sampling.
4.2. Experimental Design. Protocols (Supplementary Figures
1 and 2) and primers (Supplementary Table 1) for RT
nested PCR and sequencing of overlapping fragments was
designed based on a published protocol [11]. PCR primers
were designed to be subtype- or strain-speciﬁc, by using
alignments of available 2k/1b, 2k, and 1b sequences from
the Los Alamos HCV sequence database (http://hcv.lanl.gov/
content/index). Inner PCR primers were used for initial
sequencing of PCR products and further strain-speciﬁc
sequencing primers were subsequently designed by “primer
walking”, using theresulting sequences.Withtheassumption
that the strains would have the same recombination point
as the known 2k/1b recombinant, where the crossover
point was found to be around nucleotide 3164 (numbered
according to strain H77) [13], primers on the 5 side of
this point were designed to be 2k-speciﬁc and primers
on the 3 side were designed to be 1b-speciﬁc. Also, the
region covering this point was sequenced bidirectionally
fromthreediﬀerentPCRproductstoensuretheagreementof
sequences.
4.3. RNA Extraction, RT-PCR, and Near-Full Genome Seq-
uencing. Viral RNA was extracted from 200 µLp l a s m a
previously extracted at the initial sampling of the patients
[19], using the High Pure Viral RNA kit (Roche Diagnostics,
Manheim, Germany), following the manufacturer’s instruc-
tions.
Initially,one-stepRT-PCRreactions weresetupusingthe
Superscript III one-step RT-PCR system with Platinum Taq
high ﬁdelity (Invitrogen, Carlsbad, CA, USA) and the outer
forwardandreverseprimersaspreviouslydescribed[19].For
the nested PCR reactions, 1X Platinum PCR SuperMix High
Fidelity (Invitrogen, Carlsbad, CA, USA) was used with 3µL
of the corresponding RT-PCR product, and 20pmol each of
the inner forward and reverse PCR primers. PCR products
were visualised after electrophoresis on a 2% agarose gel and
puriﬁed using the QIAquick PCR Puriﬁcation Kit (Qiagen,
Hilden, Germany).
Cycle sequencing reactions were performed on 1µLo f
each secondary PCR products using the BigDye Termi-
nator system v3.1 (Applied Biosystems, Warrington, UK)
with 5pmol of each sequencing primer (Supplementary
Table 1), as described previously [19]. Direct population
sequencing was carried out in order to obtain consensus
sequences reﬂecting the dominant quasispecies population
in each sample. Sequences were read using the ABI 3130
Genetic Analyzer and obtained through the ABI sequencing
analysis 5.2 software (Applied Biosystems, Foster City, CA,
USA). The results were manually looked over and poly-
morphisms where double peaks were observed at equal
intensity in the chromatogram were annotated according
to standard IUB base codes. All resulting sequences of
each strain were used for stitching together the near-
full genome (nt 87-9287, numbered according to strain
H77).
4.4. Characterisation of Recombinant Strains. Simplot and
Bootscan analyses were carried out on the resulting
sequences to visualise the percentage sequence similarity
of each isolate to reference sequences along the length of
their sequence and investigate recombination. The near-
full genome sequences were aligned with reference strains
representing all HCV genotypes and all available subtypes
of the appropriate corresponding genotypes in each case in
MEGA v4 [21] and uploaded into SimPlot v3.5.1 software
(http://sray.med.som.jhmi.edu/SCRoftware/). The analysis
also included the two available 2k/1b full genome sequences,
N687 (GenBank Acc. no. AY587845) and M21 (GenBank
Acc. no. FJ821465). The analyses were carried out with
windows of 200 bases proceeding in steps of 20 bases, using
the Kimura 2-parameter distance model, and a Neighbour-
Joining tree model with 100 bootstrap replicates.
Phylogenetic analyses were carried out separately
on the genomic regions on either side of the crossover
point (positions 87-3150 and 3200-9287, resp., numbered
according to H77), in order to conﬁrm the classiﬁcation of
each region in the corresponding subtypes, by including
reference strains and the most closely related (>90%
similarity) sequences derived from an HCVBLAST search
(http://hcv.lanl.gov/content/sequence/BASIC BLAST/basic
blast.html). Sequenceswere aligned in MEGA v4 [21], where
a Neighbour-Joining tree was constructed as described
previously [19].
For visual inspection and sequence comparison, the
nucleotide sequences of the strains described here were
uploaded into MEGA v4, aligned with isolates N687 and
M21, and automatically converted to their translated protein
sequences.
4.5. Reference Sequences. The GenBank accession numbers
of the reference strains used in the construction of phylo-
genetic trees described above are seen in the corresponding
ﬁgures in the results section. For the Simplot and Bootscan
analyses, the GenBank accession numbers of the reference
sequences used are as follows: 1a.NC 004102, EF407419,
AF511950; 1b.AY587016, D11355, EF032892; 1c.D14853,
AY051292; 2a.AB047639, AY746460, D00944; 2b.AB030907,
AF238486,D10988;2c.D50409;2i.DQ155561;2k.AB031663;
2k/1b.AY587845; 2k/1b.FJ821465; 3a.X76918, AF046866,
D17763; 3b.D49374; 3k.D63821; 4a.NC 009825, DQ418788;
4d.DQ418786, DQ516083; 5a.AF064490, NC 009826; 6a.
DQ480513, Y12083; 6b.D84262; 6c.EF424629; 7a.EF108306.
Acknowledgments
The work was supported by the Cyprus Research Promotion
Foundation, Grant no. ENIΣX/0506/34,funds ofthe Univer-
sity of Cyprus, and BIRCH Biomedical.Advances in Virology 7
References
[ 1 ]Q .L .C h o o ,G .K u o ,A .J .W e i n e r ,L .R .O v e r b y ,D .W .B r a d l e y ,
and M. Houghton, “Isolation of a cDNA clone derived from
a blood-borne non-A, non-B viral hepatitis genome,” Science,
vol. 244, no. 4902, pp. 359–362, 1989.
[2] P. Simmonds, “Genetic diversity and evolution of hepatitis C
virus—15 years on,” Journal of General Virology, vol. 85, no.
11, pp. 3173–3188, 2004.
[3] P. Simmonds,J.Bukh,C. Combet et al.,“Consensus proposals
for a uniﬁed system of nomenclature of hepatitis C virus
genotypes,” Hepatology, vol. 42, no. 4, pp. 962–973, 2005.
[4] R. Colina, D. Casane,S. Vasquez et al., “Evidence of intratypic
recombination in natural populations of hepatitis C virus,”
Journal of General Virology, vol. 85, no. 1, pp. 31–37, 2004.
[5] J. Cristina and R. Colina, “Evidence of structural genomic
region recombination in Hepatitis C virus,” Virology Journal,
vol. 3, article no. 53, 2006.
[6] S. Kageyama, D. M. Agdamag, E. T. Alesna et al., “A natural
inter-genotypic (2b/1b) recombinant of hepatitis C virus in
the Philippines,” Journal of Medical Virology, vol. 78, no. 11,
pp. 1423–1428, 2006.
[7] O. Kalinina, H. Norder, S. Mukomolov, and L. O. Magnius,
“A natural intergenotypic recombinant of hepatitis C virus
identiﬁed in St. Petersburg,” Journal of Virology, vol. 76, no.
8, pp. 4034–4043, 2002.
[8] F. Legrand-Abravanel, J. Claudinon, F. Nicot et al., “New
naturalintergenotypic(2/5)recombinantofhepatitisCvirus,”
Journal of Virology, vol. 81, no. 8, pp. 4357–4362, 2007.
[ 9 ]M .P .M o r e n o ,D .C a s a n e ,L .L´ opez, and J. Cristina, “Evidence
of recombination in quasispecies populations of a Hepatitis C
virus patient undergoing anti-viral therapy,” Virology Journal,
vol. 3, article no. 87, 2006.
[ 1 0 ] P .M o r e n o ,M .A l v a r e z ,L .L ´ apez et al., “Evidence of
recombination in Hepatitis C Virus populations infecting a
hemophiliacpatient,”Virology Journal,vol.6,article203,2009.
[11] S. Noppornpanth, T. X. Lien, Y. Poovorawan, S. L. Smits, A.
D. M. E. Osterhaus, and B. L. Haagmans, “Identiﬁcation of
a naturally occurring recombinant genotype 2/6 hepatitis C
virus,”JournalofVirology,vol.80,no.15,pp.7569–7577,2006.
[12] V. Sentandreu, N. Jim´ enez-Hern´ andez, M. Torres-Puente et
al., “Evidence of recombination in intrapatient populations of
hepatitis C virus,” PLoS One, vol. 3, no. 9, Article ID e3239,
2008.
[13] O. Kalinina, H. Norder, and L. O. Magnius, “Full-length
open reading frame of a recombinant hepatitis C virus strain
from St. Petersburg: proposed mechanism for its formation,”
Journal of General Virology,vol.85,no.7,pp.1853–1857,2004.
[14] F. Kurbanov, Y. Tanaka, D. Avazova et al., “Detection of hep-
atitis C virus natural recombinant RF1 2k/1b strain among
intravenous drug users in Uzbekistan,” Hepatology Research,
vol. 38, no. 5, pp. 457–464, 2008.
[15] F. Kurbanov, Y. Tanaka, E. Chub et al., “Molecular epidemiol-
ogy and interferon susceptibility of the natural recombinant
hepatitis C virus strain RF1 2k/1b,” Journal of Infectious
Diseases, vol. 198, no. 10, pp. 1448–1456, 2008.
[16] I. Moreau, S. Hegarty, J. Levis et al., “Serendipitous identiﬁca-
tion of natural Intergenotypic recombinants of hepatitis C in
Ireland,” Virology Journal, vol. 3, article 95, 2006.
[17] V. Morel, V. Descamps, C. Franc ¸ois et al., “Emergence of a
genomic variant of the recombinant 2k/1b strain during a
mixed Hepatitis C infection: a case report,” Journal of Clinical
Virology, vol. 47, no. 4, pp. 382–386, 2010.
[18] T. Tallo, H. Norder, V. Tefanova et al., “Genetic character-
ization of hepatitis C virus strains in Estonia: ﬂuctuations
in the predominating subtype with time,” Journal of Medical
Virology, vol. 79, no. 4, pp. 374–382, 2007.
[19] V. L. Demetriou, D. A. M. C. Van De Vijver, L. G. Kostrikis
et al., “Molecular epidemiology of hepatitis C infection in
cyprus: evidence of polyphyletic infection,” Journal of Medical
Virology, vol. 81, no. 2, pp. 238–248, 2009.
[20] N. Enomoto, I. Sakuma, Y. Asahina et al., “Mutations in the
nonstructural protein 5A gene and response to interferon in
patients with chronic hepatitis C virus 1b infection,” New
England Journal of Medicine, vol. 334, no. 2, pp. 77–81, 1996.
[ 2 1 ]K .T a m u r a ,J .D u d l e y ,M .N e i ,a n dS .K u m a r ,“ M E G A 4 :
Molecular Evolutionary Genetics Analysis (MEGA) software
version 4.0,” Molecular Biology and Evolution, vol. 24, no. 8,
pp. 1596–1599, 2007.